545 related articles for article (PubMed ID: 9641173)
21. [The kidney in multiple myeloma. The physiopathological and clinical aspects].
Vivaldi P; Comotti C; Pedrazzoli M
Recenti Prog Med; 1994 Feb; 85(2):123-33. PubMed ID: 8184190
[TBL] [Abstract][Full Text] [Related]
22. [Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma].
Renal Impairment of Multiple Myeloma Collaborative Study Group
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):871-875. PubMed ID: 29136724
[TBL] [Abstract][Full Text] [Related]
23. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
Bird JM; Fuge R; Sirohi B; Apperley JF; Hunter A; Snowden J; Mahendra P; Milligan D; Byrne J; Littlewood T; Fegan C; McQuaker G; Pagliuca A; Johnson P; Rahemtulla A; Morris C; Marks DI;
Br J Haematol; 2006 Aug; 134(4):385-90. PubMed ID: 16822294
[TBL] [Abstract][Full Text] [Related]
24. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
[TBL] [Abstract][Full Text] [Related]
25. Hemodialysis: an appropriate therapy in myeloma-induced renal failure.
Sharland A; Snowdon L; Joshua DE; Gibson J; Tiller DJ
Am J Kidney Dis; 1997 Dec; 30(6):786-92. PubMed ID: 9398122
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
27. Renal replacement therapy in multiple myeloma and systemic amyloidosis.
Brown JH; Maxwell AP; Bruce I; Murphy BG; Doherty CC
Ir J Med Sci; 1993 Jun; 162(6):213-7. PubMed ID: 8407257
[TBL] [Abstract][Full Text] [Related]
28. Presentation and survival of patients with severe renal failure and myeloma.
Irish AB; Winearls CG; Littlewood T
QJM; 1997 Dec; 90(12):773-80. PubMed ID: 9536342
[TBL] [Abstract][Full Text] [Related]
29. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
Yadav P; Hutchison CA; Basnayake K; Stringer S; Jesky M; Fifer L; Snell K; Pinney J; Drayson MT; Cook M; Cockwell P
Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in light chain amyloidosis].
Jávorniczky NR; Bodó I; Masszi T; Mikala G
Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
[TBL] [Abstract][Full Text] [Related]
31. [Renal involvement in monoclonal gammopathies].
Ibáñez Moreno JA; Bacca González JM; Taborda Murillo A; Ospina Ospina S; Arias LF
Rev Esp Patol; 2022; 55(1):4-11. PubMed ID: 34980439
[TBL] [Abstract][Full Text] [Related]
32. [Clinical Characteristics and Therapeutic Efficacy of Multiple Myeloma Combined with Renal Amyloidosis].
Wen HY; Gan SL; Ma J; Xie XS; Liu YF; Jiang ZX; Sun L; Liu LX; Wang F; Meng XL; Chen SQ; Chen YD; Wan DM; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):474-7. PubMed ID: 27151013
[TBL] [Abstract][Full Text] [Related]
33. [Renal diseases in monoclonal gammopathies].
Kościelska M; Graczyk M
Wiad Lek; 2015; 68(4 Pt 2):646-9. PubMed ID: 27162303
[TBL] [Abstract][Full Text] [Related]
34. Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience.
Hernández-Reyes J; Galo-Hooker E; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2012; 64(6 Pt 2):604-8. PubMed ID: 23593777
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
[TBL] [Abstract][Full Text] [Related]
36. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
[TBL] [Abstract][Full Text] [Related]
37. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
38. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
Herrera GA
Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
[TBL] [Abstract][Full Text] [Related]
39. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.
Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH
Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324
[TBL] [Abstract][Full Text] [Related]
40. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
